From her LinkedIn:

My #1 priority is to leave the world better than I found it.

Throughout my career as a Hopkins-trained epidemiologist and healthcare business innovator and entrepreneur, I’ve always had my eye and my heart on the world’s most marginalized and underserved populations. My primary motivator has never been the prestige of being a Johns Hopkins scientist. It has always been patient advocacy. Working to influence healthcare policy and navigating companies with promising research and medical technologies through this complex marketplace can transform healthcare from the top down and the bottom up.

In this industry, what I often see is a disconnect between innovation and our highly regulated medical landscape. My team and I work to bridge this gap, to help MedTech companies understand how to navigate the complex healthcare landscape with integrity so they can not only bring true innovation to the market but can also operate across the entire business lifecycle.

I bring a unique combination of expertise and experience as both an executive and a scientist with 20+ years of leading and executing real-world evidence strategy, evidence generation, clinical-economic studies, analytics, post-market study design, and value communication. The breadth and depth of my journey has given me a comprehensive integrated view of the marketplace as I work to bridge the gaps that hinder healthcare innovation from reaching patients.

I believe in maximizing the micro-opportunities of addressing humanity’s rarest diseases – which impact only 1% of the population – with new research and emerging medical technologies. As a family member and caregiver of patients with rare congenital defects, I am personally vested in changing the hierarchical model of healthcare to place the patient and the provider back at the center. My success in designing studies that impact policy change is a value-add to companies pursuing opportunities to enter the market.

From his LinkedIn:

The experience I gathered over the last 28 years in industry and a non-profit organization has provided me with insights in several technological areas, ranging from immunoassays to biosensors and nucleic acid purification. I am familiar with the management of R&D activities in a regulated environment, including project and human resources management, auditing, and QC. I am experienced with the implementation and maintenance of quality management systems and regulatory affairs.

Software engineer and entrepreneur with a passion for securely bringing new technologies to safety critical industries like medical devices, avionics and industrial automation.

From his LinkedIn:

Michael “Mick” Farrell is Chairman & CEO of ResMed based at our global headquarters in San Diego, California. ResMed is the global leader in the development, manufacturing and marketing of innovative medical products and digital health solutions for the treatment and management of respiratory medicine, with a focus on sleep apnea and respiratory insufficiency due to COPD and NMD; we are also the global strategic leader in software solutions for residential care, with software-as-a-service (SaaS) solutions for home medical equipment, home health, home nursing, and beyond! In the last twelve months we touched more than 149 million lives, helping people sleep better, breathe better, and to live longer with the best outside-hospital care.

We will continue to develop our future vision: improving lives for patients with sleep apnea, COPD, NMD, asthma, insomnia, and other key chronic diseases. We sell a comprehensive range of medical software as well as respiratory medical products in more than 140 countries worldwide.

We are committed to advancing innovative technology in sleep and respiratory medicine and commercializing innovative products and solutions, delivering and scaling these technologies on a global basis. With more than 19 million 100% cloud-connectable medical devices in the market and over 13.5 billion nights of medical data in the cloud, we are the world’s leading digital-health-driven medical device company.

Most importantly, we are improving hundreds of millions of lives, with an ambition to help 250 million lives with market-leading healthcare solutions in 2025… caring for people well-away from the hospital, and preferably in their own home.

Sean McKibben is a senior healthcare executive with a proven record of accomplishments leading successful growth, expansion, and operational improvements of health care organizations. In 2020 after 25 years of senior level experience including sixteen successful years as serving as a hospital President, Mr. McKibben decided to follow his passion to significantly improve patient outcomes through the use of innovation and technology and began his journey in the startup world.

In May of 2021 Sean was named the Chief Operating Officer for DASI Simulations after serving as an executive advisor for the start up since October 2020. DASI Simulations focuses on improving the safety of care for Structural Heart Disease patients by providing innovative personalized simulations using artificial intelligence and computational predictive modeling.

Sean also is serving as an Executive Business Advisor for several startups in the Life Sciences and Healthcare technology industry. These organizations are focused on improving patient outcomes, enhancing patient/provider experiences, and improving the efficiency and effectiveness of care.

Hilary grew up in the medtech world where she started on an inside sales team for a newly acquired medical company. From there she quickly transitioned to an outside role and worked her way up to most recently run a sales and clinical team across 3 different divisions for a global Medtech company.

She has carried the bag, led teams, and has extensive experience in selling disposables, medical software, capital equipment, and medical devices. Hilary has a deep understanding of navigating the complex clinical evaluation, sales, and implementation process into hospitals and healthcare systems. Medical technology has life-changing effects on patients and families but we must first get the technology to the patient. Hilary’s passion lies in guiding startups through this to ensure their technology makes it to patients. She also ushers founders in creating and implementing a sales process to ensure their growth and sales are scalable.

Hilary is the founder of Rebel Scout Consulting which provides fractional sales leadership to startups and serves as a mentor to VC accelerator programs.

From his LinkedIn: I am an executive leader who specializes in inspiring teams to design and implement innovations to successfully solve problems. I am an optimist who gravitates to mission-driven “big ideas” and I empower my colleagues to realize this vision through disciplined implementation, relentless focus and strategic alignment. My social entrepreneurship began at 13 years of age following the tragic death of a friend in front of my childhood home. Following this tragedy, I led the lobbying effort to pass the nation’s first bicycle helmet law for children. I learned at a young age that someone like me – who wasn’t born into a famous or wealthy family – could make a difference in the world.

Over my career, I’ve been blessed to work for and help build amazing companies which have made a positive impact – as a Team Leader at the Eli Lilly e.Lilly venture fund where we funded and piloted new digital health technologies; former manager of digital health for Johnson & Johnson’s largest product where I helped launched www.Cancer.com; and helped direct marketing efforts for Prometheus Laboratories to pioneer personalized gastroenterology. The Baltimore Sun selected me as one of five “Earthly Angels”. In 2016, I was chosen as the Emerging Technology Company CEO of the Year by OCTANe, as an Excellence in Entrepreneurship Winner from the OC Business Journal, and a two-time finalist for the EY Entrepreneur of the Year Award. As a pioneer in big data and precision medicine, I founded Proove Biosciences in 2009 which became one of the fastest growing technology companies in North America – ranked in the Deloitte Technology Fast 500 and the Inc. 500. In 2010, I became the youngest ever-elected school board member for one of the nation’s leading school systems. Today, I am the Managing Partner of Profound Ventures – a seed stage impact fund, as well as consulting with numerous companies to help them achieve their goals to positively impact the world.

30 years of experience driving market and business growth on a global basis for technology companies. Primary expertise is market development strategy for medical companies — delivering growth in a highly regulated industry. My style blends rigorous novel analytics with a people-oriented organizational leadership philosophy.

My goal is to help companies create affordable healthcare solutions that improve patient outcomes or prevent disease. I am an experienced professional in the development and regulatory approval of medical devices through the entire product life-cycle.

I understand the regulatory requirements, and how to create compliant processes that add business value. I have experience in process improvement and training from R&D, business performance, and Quality perspectives.

My medical device experience includes external defibrillators and pacemakers, multi-parameter patient monitors, medical software, sterilizable accessories, ultrasound surgical devices, and electrical stimulation equipment.

I specialize in helping small startup medical device companies with their Quality System’s needs. I can help medical device companies implement a vPAPER (virtual paper) Quality Management Systems, document control, data organization, process DCOs, and maintain a Master Index of all document control relevant information, establish employee qualification, identify, and establish employee training programs, supplier control program and qualify suppliers, CAPA program, provide CAPA process training, provide Root Cause analysis training, implement and manage CAPA program, perform Quality System gap assessments and suggest potential opportunities for improvement.